Pulse Biosciences, Inc.
PLSE
$17.74
$0.855.03%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -52.88% | -11.39% | -12.29% | 15.05% | -12.94% |
| Total Depreciation and Amortization | -2.38% | -1.34% | -0.33% | -1.64% | 1.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 128.00% | 45.32% | 16.66% | -47.60% | 86.71% |
| Change in Net Operating Assets | 730.26% | -40.44% | 137.51% | -214.16% | 173.84% |
| Cash from Operations | -1.33% | -7.49% | 14.16% | -44.21% | 35.33% |
| Capital Expenditure | -39.47% | -31.03% | -480.00% | 88.37% | -86.96% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -39.47% | -31.03% | -480.00% | 88.37% | -86.96% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -21.96% | 475,615.38% | -95.74% | -62.06% | 98.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -205.36% | 120.14% | -- | -- | 100.00% |
| Cash from Financing | -22.13% | 23,458.11% | -186.89% | -62.06% | -62.59% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -26.18% | 708.09% | 8.34% | -57.45% | 27.99% |